Latest 5-HT3 antagonist Stories
LUGANO, Switzerland, May 19, 2015 /PRNewswire/ -- Helsinn, a Swiss Group focused on building quality cancer care, announced today that three abstracts highlighting new
Company demonstrates dedication to rare cancers WOODCLIFF LAKE, N.J., May 14, 2015 /PRNewswire/ -- Eisai Inc.
-- First New Fixed Combination Targeting Two Critical Pathways Involved in CINV MELBOURNE, Australia and LUGANO, Switzerland, May 8, 2015 /PRNewswire/ -- Australian biopharmaceutical company
CAMBRIDGE, England, May 6, 2015 /PRNewswire/ -- - Primary Endpoint of Preventing Delayed CINV Met With High Significance Acacia Pharma Ltd ("Acacia Pharma"
CAMBRIDGE, England, April 21, 2015 /PRNewswire/ -- Acacia Pharma Ltd ("Acacia Pharma" or "the Company"), the supportive care company developing products for US and international
LUGANO, Switzerland and WOODCLIFF LAKE, N.J., April 15, 2015 /PRNewswire/ -- Helsinn Group and Eisai Inc.
Robert Gardner Law has created a new resource site to investigate claims following a U.S. Justice department criminal plea agreement with GlaxoSmithKline.
Zofran Lawsuits Claim Heart Birth Defects, Kidney Malformations And Other Serious Congenital Abnormalities When Taken By Pregnant Women To Control Severe Morning Sickness Chicago,
LUGANO, Switzerland, March 30, 2015 /PRNewswire/ -- First New Fixed Dose Combination Targeting Two Key Pathways Involved in CINV Helsinn, the Swiss Group
In light of two recently filed Zofran lawsuits, the San Diego personal injury attorneys of The Law Office of Melinda J. Helbock, A.P.C.
- A hairdresser.